Single Cell Technology adds to international porfolio of patents

Single Cell Technology has expanded its international patent portfolio, India Patent No. 296142 titled "Method of screening single cells for the production of biologically active agent" was issued on Apr. 25, 2018. This patent brings the total number of issued international patents to 6 and total issued patents to 11. Patents are also held in Canada, South Korea, Europe, Australia, and Japan.

Dr. Chun-Nan Chen, Founder and CEO has been the driving force behind the impressive number of patents protecting SCT technology. "This patent covers SCT's core methodology in the broadest applications including but not limited to antibody discovery. The invention can be used for T cell receptor identification and beyond," he commented.